Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

3.79
+0.22006.16%
Post-market: 3.880.0900+2.37%19:58 EDT
Volume:2.85M
Turnover:10.96M
Market Cap:55.17M
PE:-0.31
High:4.04
Open:3.56
Low:3.56
Close:3.57
52wk High:13.36
52wk Low:1.17
Shares:14.56M
Float Shares:5.51M
Volume Ratio:0.85
T/O Rate:51.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.2842
EPS(LYR):-23.5105
ROE:-1766.94%
ROA:-68.72%
PB:-0.51
PE(LYR):-0.16

Loading ...

Top Premarket Gainers

MT Newswires Live
·
Aug 18

BioXcel Therapeutics Inc - to Submit Bxcl501 Snda in Q1 2026

THOMSON REUTERS
·
Aug 18

HC Wainwright Adjusts Price Target on BioXcel Therapeutics to $10 From $8, Maintains Buy Rating

MT Newswires Live
·
Aug 15

BioXcel Therapeutics Inc - Receives Positive Preliminary Comments From FDA for Pre-Snda, Meeting Scheduled for Aug 20 - SEC Filing

THOMSON REUTERS
·
Aug 15

BioXcel Therapeutics Inc. Receives Positive Feedback from FDA Ahead of Pre-sNDA Meeting Scheduled for August 20, 2025

Reuters
·
Aug 15

BioXcel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12

BioXcel Therapeutics Q2 Basic EPS USD -2.45 Vs. IBES Estimate USD -1.86

Reuters
·
Aug 12

BioXcel Therapeutics Q2 Operating Expenses USD 15.972 Million

THOMSON REUTERS
·
Aug 12

BioXcel Therapeutics Q2 Net Income USD -19.187 Million VS. Ibes Estimate USD -12.8 Million

THOMSON REUTERS
·
Aug 12

BioXcel Therapeutics Inc. Unveils Presentation on BXCL501's Commercial Potential for At-Home Treatment of Bipolar and Schizophrenia Agitation

Reuters
·
Aug 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

BioXcel Therapeutics Inc expected to post a loss of $1.63 a share - Earnings Preview

Reuters
·
Aug 01

BioXcel Therapeutics Inc - Topline Data Readout Anticipated This Month

THOMSON REUTERS
·
Aug 01

Mizuho Slashes Price Target on BioXcel Therapeutics to $2 From $16, Keeps Neutral Rating

MT Newswires Live
·
Jul 28

BRIEF-Bioxcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package In Support Of Potential Label Expansion For Igalmi

Reuters
·
Jul 21